AU3005499A - Induction and enhancement of the immune response to type-2 cell-independent antigens conjugated to lipid or lipid-containing moieties - Google Patents
Induction and enhancement of the immune response to type-2 cell-independent antigens conjugated to lipid or lipid-containing moietiesInfo
- Publication number
- AU3005499A AU3005499A AU30054/99A AU3005499A AU3005499A AU 3005499 A AU3005499 A AU 3005499A AU 30054/99 A AU30054/99 A AU 30054/99A AU 3005499 A AU3005499 A AU 3005499A AU 3005499 A AU3005499 A AU 3005499A
- Authority
- AU
- Australia
- Prior art keywords
- lipid
- enhancement
- induction
- cell
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3924798A | 1998-03-16 | 1998-03-16 | |
| US09039247 | 1998-03-16 | ||
| PCT/US1999/005647 WO1999047168A2 (en) | 1998-03-16 | 1999-03-15 | Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3005499A true AU3005499A (en) | 1999-10-11 |
Family
ID=21904454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30054/99A Abandoned AU3005499A (en) | 1998-03-16 | 1999-03-15 | Induction and enhancement of the immune response to type-2 cell-independent antigens conjugated to lipid or lipid-containing moieties |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3005499A (en) |
| WO (1) | WO1999047168A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO329958B1 (en) * | 1999-09-17 | 2011-01-31 | Pfizer Canada Inc | Use of an immunogenic amount of OspA lipoprotein from Piscirickettsia salmonis, OspA antigen, and immunogenic promiscuous TCE in an OspA chimeric fusion protein, for the preparation of drugs, and in vitro . |
| AU8640501A (en) * | 2000-07-31 | 2002-02-13 | Univ Yale | Innate immune system-directed vaccines |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE254475T1 (en) * | 1993-09-22 | 2003-12-15 | Jackson H M Found Military Med | METHOD FOR ACTIVATION OF SOLUBLE CARBOHYDRATES BY USING NEW CYANYLATION REAGENTS TO PRODUCE IMMUNOGENIC CONSTRUCTS |
| EP0824360A1 (en) * | 1995-04-17 | 1998-02-25 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins |
-
1999
- 1999-03-15 AU AU30054/99A patent/AU3005499A/en not_active Abandoned
- 1999-03-15 WO PCT/US1999/005647 patent/WO1999047168A2/en active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999047168A3 (en) | 1999-12-23 |
| WO1999047168A2 (en) | 1999-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3456099A (en) | Methods and compositions for eliciting an immune response to a telomerase antigen | |
| EP0862507A4 (en) | Enhancement of thermal properties of tooling made by solid free form fabrication techniques | |
| AU4570699A (en) | Nucleosidic and non-nucleosidic folate conjugates | |
| ZA964850B (en) | The regulation of systemic immune response utilizing cytokines and antigens | |
| EP0744557A3 (en) | Self-energizing synchronizer | |
| HUP9903770A3 (en) | Method and composition for reconforming multi-epitopic antigens to initiate an immune response | |
| EP0747607A3 (en) | Electromagnetic friction joint | |
| AU3005499A (en) | Induction and enhancement of the immune response to type-2 cell-independent antigens conjugated to lipid or lipid-containing moieties | |
| AU1908395A (en) | Antibodies to mammalian natural killer antigens and uses | |
| AU5688596A (en) | Anti-cd14 antibodies for use in the induction of il-10 secre tion | |
| GB9516492D0 (en) | Synchronizer with self-energizing | |
| AU3179999A (en) | Methods to treat undesirable immune responses | |
| AU1669695A (en) | Hot surface igniter | |
| AU2002249917A1 (en) | Induction of immune responses to isoaspartyl-modified antigens | |
| GB2309459B (en) | Antibodies to fungal antigens | |
| EP1221961A4 (en) | Induction of a strong immune response to a self-tumor associated antigen | |
| AU7585998A (en) | Controlling immune response to specific antigens | |
| AU7831898A (en) | Induction of immune tolerance by immunotoxin | |
| AU1874997A (en) | Molecules for the induction of immunological tolerance | |
| PL346796A1 (en) | Methods of downmodulating the immune response to therapeutic proteins | |
| GB9402994D0 (en) | Preparation of embossing shims | |
| AU7410496A (en) | Method to increase and modify immune responses | |
| AU2828795A (en) | Monoclonal antibodies for the reduction of anti-xenogeneic immune responses | |
| IL127249A0 (en) | Human monoclonal antibodies to the hepatitis b surface antigen | |
| AU1677395A (en) | Evaluation of red-dot hiv 1 and 2 for the detection of antibodies to hiv 1 and 2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |